High-yield, stably expressing cell lines are of critical importance for economically viable biopharmaceutical production processes. Development of clonal mammalian producer cell lines is a complex, lengthy, and costly process. Large numbers of cell pools and clones must be generated, screened, and tested to identify producer cell lines suitable for industrial, large-scale manufacturing processes, and this results in huge amounts of data that need to be captured, analyzed, and reported.
Genedata Bioprocess® supports the full cell line development (CLD) workflow and improves efficiency of the entire clone selection process – from initial transfection all the way to the final clone assessment and cell banking. The platform reduces timelines and costs to generate robust, clonal, and highly productive cell lines for manufacturing processes, and includes all necessary documentation.
